PRODUCT LITERATURE
A n open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain
Studies of pregabalin for the treatment of central neuropathic pain have been limited to double-blind trials of 4–17 weeks in duration. The purpose of this study was to assess the long-term safety and tolerability of pregabalin in Japanese patients with central neuropathic pain. The efficacy of pregabalin was also assessed as a secondary measure.
No other version available